Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma

Published:2020-07-22 Issue:2 Volume:42 Page:301-310
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Li Zhong-jie,Dai Hui-qi,Huang Xiao-wei,Feng Ji,Deng Jing-huan,Wang Zi-xuan,Yang Xiao-mei,Liu Yu-jia,Wu Yong,Chen Pan-hong,Shi Huan,Wang Ji-gang,Zhou Jing,Lu Guo-dong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-020-0478-3.pdf

Reference38 articles.

1. Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol. 2012;10:34–42.

2. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.

3. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90.

4. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25–34.

5. Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15:599–616.

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A TCM formula assists temozolomide in anti-melanoma therapy by suppressing the STAT3 signaling pathway;Journal of Ethnopharmacology;2025-01

2. Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors;Bioorganic & Medicinal Chemistry;2024-10

3. Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma;Chinese Chemical Letters;2024-10

4. Sorafenib, a Tyrosine Kinase Inhibitor, Synergistically Enhances the Ferroptosis Effects of Asiatic Acid in Hepatocellular Carcinoma Cells;Environmental Toxicology;2024-09-12

5. Ferritin Hinders Ferroptosis in Non-Tumorous Diseases: Regulatory Mechanisms and Potential Consequences;Current Protein & Peptide Science;2024-09-02